Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
R341442-10μg | 10μg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $539.90 |
an anti-inflammatory that reduces human polymorphonuclear leukocyte transendothelial migration
Synonyms | 17(R)-Resolvin D1 | SB48260 | RvD1 | Resolvin D1 | 7,8,17-TRIHYDROXYDOCOSA-4,9,11,13,15,19-HEXAENOIC ACID | 17(R)-RvD1 | DTXSID60694000 |
---|---|
Specifications & Purity | Moligand™, ≥95%, A solution in ethanol |
Storage Temp | Protected from light,Store at -80°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | AGONIST, GATING INHIBITOR |
Mechanism of action | Agonist of FPR2/ALX;Agonist of GPR32;Gating inhibitor of TRPA1 |
Product Description | Resolvin D1 is from a family of potent lipid mediators derived from both eicosapentaenoic acid (EPA) and docosahexaenoic (DHA)(1), it is an anti-inflammatory and promotes the resolution of the inflammatory response back to a non-inflamed state.2 RvD1 is produced physiologically from the sequential oxygenation of DHA by 15- and 5-lipoxygenase. It reduces human polymorphonuclear leukocyte (PMNL) transendothelial migration, the earliest event in acute inflammation, with EC50 values of ~30 nM. It exhibits a dose-dependent reduction in leukocyte infiltration in a murine model of peritonitis with a maximal inhibition of ~35% at a 10-100 ng dose. Resolvin D1 (RvD1) is supplied as a solution in ethanol. To change the solvent, simply evaporate the ethanol under a gentle stream of nitrogen and immediately add the solvent of choice. It is recommended that this product be stored and handled in an ethanol solution. Resolvins can isomerize and degrade when put into freeze thaw conditions and/or in solvents such as dimethyl formamide or DMSO. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 7,8,17-trihydroxydocosa-4,9,11,13,15,19-hexaenoic acid |
---|---|
INCHI | InChI=1S/C22H32O5/c1-2-3-9-14-19(23)15-10-6-4-5-7-11-16-20(24)21(25)17-12-8-13-18-22(26)27/h3-12,15-16,19-21,23-25H,2,13-14,17-18H2,1H3,(H,26,27) |
InChi Key | OIWTWACQMDFHJG-UHFFFAOYSA-N |
Canonical SMILES | CCC=CCC(C=CC=CC=CC=CC(C(CC=CCCC(=O)O)O)O)O |
Isomeric SMILES | CCC=CCC(C=CC=CC=CC=CC(C(CC=CCCC(=O)O)O)O)O |
PubChem CID | 53394122 |
Molecular Weight | 376.5 |
CAS Registry No. | 872993-05-0 |
---|---|
PubChem CID | 73755062 |
GPCRdb Ligand | resolvin D1 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
H2422504 | Certificate of Analysis | Aug 15, 2024 | R341442 |
E2429501 | Certificate of Analysis | Apr 23, 2024 | R341442 |
H2309197 | Certificate of Analysis | Jul 25, 2023 | R341442 |
G2303071 | Certificate of Analysis | Jun 09, 2023 | R341442 |
Solubility | Soluble in water (0.05 mg/mL) at 25° C, PBS pH 7.2 (~0.05 mg/mL), DMSO (~50 mg/mL), DMF (~50 mg/mL), and ethanol. |
---|---|
Sensitivity | Light sensitive |
Boil Point(°C) | 78° C |
Starting at $900.90
Starting at $237.90
1. Colby JK, Abdulnour RE, Sham HP, Dalli J, Colas RA, Winkler JW, Hellmann J, Wong B, Cui Y, El-Chemaly S et al.. (2016) Resolvin D3 and Aspirin-Triggered Resolvin D3 Are Protective for Injured Epithelia.. Am J Pathol, 186 (7): (1801-1813). [PMID:27171898] [10.1021/op500134e] |
2. Zhang MJ, Sansbury BE, Hellmann J, Baker JF, Guo L, Parmer CM, Prenner JC, Conklin DJ, Bhatnagar A, Creager MA et al.. (2016) Resolvin D2 Enhances Postischemic Revascularization While Resolving Inflammation.. Circulation, 134 (9): (666-680). [PMID:27507404] [10.1021/op500134e] |
3. Codagnone M, Cianci E, Lamolinara A, Mari VC, Nespoli A, Isopi E, Mattoscio D, Arita M, Bragonzi A, Iezzi M et al.. (2018) Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection.. Mucosal Immunol, 11 (1): (35-49). [PMID:28422188] [10.1021/op500134e] |